L
Lembas at ObesityWeek 2026
Nov 14–17, 2026 National Harbor, MD ~4.4k attendees Website
Lembas brings 2 presentations to ObesityWeek 2026 in National Harbor. Its program centres on GLP-1 Edge, an oral GPR40 agonist that acts locally in the gut to support weight management. One study reports better blood sugar control after meals in adults with prediabetes and obesity.
| Organization | ObesityWeek 2026 Attendance |
|---|---|
L Lembas | |
Israeli startup developing a food-grade bioactive peptide, for use in foods and supplements, that boosts the body's own GLP-1 response. | Poster Sat Nov 14 7:30pm–8:30pm GLP-1 Edge™ Improves Postprandial Glycemic Control in Adults With Prediabetes and Obesity Obesity pharmacotherapy and drug developmentMetabolism and integrative physiology Poster Sat Nov 14 7:30pm–8:30pm GLP-Edg: A Novel, Orally Administered GPR40 Agonist With a Local GI-Targeted Mechanism for Weight Management Obesity pharmacotherapy and drug developmentMetabolism and integrative physiology |
Find decision makers at Lembas
Tell us what you sell and we’ll find the people at Lembas most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by The Obesity Society (TOS), ObesityWeek® or the American Society for Metabolic and Bariatric Surgery (ASMBS). Submit a correction